Laminar distribution of β-amyloid (Aβ) peptide deposits in the frontal lobe in familial and sporadic Alzheimer's disease

Folia Neuropathologica

Volumn 53, Issue 1, 2015, Pages 15-23

  Armstrong, Richard A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Gene mutation; Laminar distribution; amyloid (A ) peptide deposits

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; DEGENERATIVE DISEASE; FAMILIAL DISEASE; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; NEUROPATHOLOGY; ONSET AGE; VERY ELDERLY; AMYLOID PLAQUE; METABOLISM; PATHOLOGY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; PLAQUE, AMYLOID;

EID: 84925830612     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2015.49970     Document Type: Article

References (55)

1. Akiyama H, Yamada T, McGeer PL, Kawamata T, Tooyama I, Ishii T. Columnar arrangement of beta-amyloid deposits in the cerebral cortex of patients with Alzheimer's disease. Acta Neuropathol 1993;85:400-403.
2. Armstrong RA. β-amyloid (Aβ) deposits and blood vessels: laminar distribution in frontal cortex of patients with Alzheimer's disease. Neurosci Res Comms 1996;18:19-28.
3. Armstrong RA. β-amyloid plaques: stages in life history or independent origin? Dement Geriatr Cogn Disord 1998;9:227-238.
4. Armstrong RA. Diffuse β-amyloid (Aβ) deposits and neurons: in situ secretion or diffusion of Aβ? Alz Rep 2001;3:289-294.
5. Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol 2006;44:1-11.
6. Armstrong R. Classic β-amyloid deposits cluster around large diameter blood vessels rather than capillaries in sporadic Alzheimer's disease. Curr Neurovasc Res 2006;3:289-294.
7. Armstrong RA. Spatial correlations between β-amyloid (Aβ) deposits and blood vessels in familial Alzheimer's disease. Folia Neuropathol 2009;46:241-248.
8. Armstrong RA. A spatial pattern analysis of β-amyloid (Aβ) deposition in the temporal lobe in Alzheimer's disease. Folia Neuropathol 2010;48:67-74.
9. Armstrong RA. Quantitative methods in neuropathology. Folia Neuropathol 2010;48:217-230.
10. Armstrong RA. Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease. Folia Neuropathol 2011;49:153-161.
11. Armstrong RA. β-amyloid (Aβ) deposition in cognitively normal brain, dementia with Lewy bodies, and Alzheimer's disease. Folia Neuropathol 2012;50:130-139.
12. Armstrong RA. Size frequency distributions of β-amyloid (Aβ) deposits: a comparative study of four neurodegenerative disorders. Folia Neuropathol 2012;50:240-249.
13. Bahmanyar S, Higgins GA, Goldgaber D. Localization of amyloid β protein messenger RNA in brains from patients with Alzheimer's disease. Science 1987;237:77-80.
14. Bussiere T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M. Morphological characterization of thioflavin-S-positive plaques in transgenic Alzheimer mice and effect of passive Aβ immunotherapy on their clearance. Am J Pathol 2004;165:987-995.
15. Braak H, Braak E, Kalus P. Alzheimer's disease: areal and laminar pathology in the occipital isocortex. Acta Neuropathol 1989;77:494-506.
16. Cairns NJ, Chadwick A, Lantos PL, Levy R, Rossor M. βA4 protein load in familial Alzheimer's disease with the mutation in codon 717 of the βA4 amyloid precursor protein gene and sporadic Alzheimer's disease. Neurosci Lett 1993;149:137-140.
17. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Rocques P, Hardy J, Mullan M. Early onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991;353:844-846.
18. Citron M, Oltersdorf T, Haass C, McCoulogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ. Mutation of β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-674.
19. Delaere P, Duyckaerts C, Brion J P, Poulain V, Hauw JJ. Tau, paired helical filaments and amyloid in the neocortex: A morphometric study of 15 cases with graded intellectual status in aging and senile dementia of the Alzheimer type. Acta Neuropathol 1989;77:645-653.
20. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distribution of β/A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 1991;81:328-335.
21. Delacourte A, Sergeant N, Champain D. Wattez A, Maurage CA, Lebert F, Pasquier F, David JP. Nonoverlapping but synergetic tau and amyloid precursor protein pathologies in sporadic Alzheimer's disease. Neurology 2002;59:398-407.
22. De Lacoste M, White CL III. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging 1993;14:1-16.
23. Duyckaerts C, Hauw JJ, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol 1986;70:249-256.
24. Gearing M, Schneider JA, Robins RS, Hollister RD, Mori H, Games D, Hyman BT, Mirra SS. Regional variations in the distribution of Apolipoprotein E and Aβ in Alzheimer's disease. J Neuropath Exp Neurol 1995;54:833-841.
25. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein, Biochem Biophys Res Commun 1984;122:1131-1135.
26. Goate R, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance, Roses A, Williamson R, Rossor M, Owen M, Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (London) 1991;349:704-706.
27. Grazini M, Prabas J, Silva F, Oliveira S, Santana I, Oliveira C. Genetic basis of Alzheimer's dementia: role of mitochondrial DNA mutations. Genes, Brain, and Behaviour 2006;5(Suppl 2):92-107.
28. Hardy JA, Higgins GA. Alzheimer's disease: The amyloid cascade hypothesis. Science 1992;256:184-185.
29. Hoenicka J. Genes in Alzheimer's disease. Revista de Neurolgia 2006;42:302-305.
30. Jellinger KA, Bancher C. Neuropathology of Alzheimer's disease: a critical update. J Neural Transm 1998;54:77-95.
31. Kida E, Pluta R, Lossinsky AS, Golabek AA, Choimiura NH, Wisniewski HM, Mossakowski MJ. Complete cerebral ischemia with short-term survival in rat induced by cardiac-arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res 1995;674:341-346.
32. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, Schellenberg GD. A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973.
33. McCauley JL, Hahs DW, Jiang L, Scott WK, Welsh-Bohmer KA, Jackson CE, Vance JM, Pericak-Vance MA, Haines JL. Combinatorial Mismatch Scan (CMS) for loci associated with dementia in the Amish. BMC Med Genet 2006;7:19.
34. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes J P, van Belle G, Berg L, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
35. Newell KL, Hyman BT, Growden JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Insitute criteria for the neuropathological diagnosis of Alzheimer's disease. J Neuropathol Exp Neurol 1999;58:1147-1155.
36. Nochlin D, Van Belle G, Bird TD, Sumi SM. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Alz Dis Assoc Dis 1993;7:212-222.
37. Pluta R, Barcikowska M, Januszewski S, Misicka A, Lipkowski AW. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide. Neuroreport 1996;7:1261-1265.
38. Pluta R, Jabloński M, Czuczwar SJ. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide. Folia Neuropathol 2012;50:101-109.
39. Pluta R, Kocki J, Maciejewski R, Ulamek-Koziol M, Jabloński M, Bogucka-Kocka A, Czuczwar SJ. Ischemia signalling to Alzheimer-related genes. Folia Neuropathol 2012;50:322-329.
40. Pluta R, Furmaga-Jablonska W, Maciejewski R, Ulamek-Koziol M, Jablonski M. Brain ischaemia activates beta- and gamma-secretase cleavage of amyloid precursor protein: Significance in sporadic Alzheimer's disease. Mol Neurobiol 2013;47:425-434.
41. Pluta R, Jablonski M, Ulamek-Koziol M, Kocki J, Brzozowska J, Januszewski S, Furmaga-Jablonska W, Bogucka-Kocka A, Maciejewski R, Czuczwar S. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes. Mol Neurobiol 2013;48:500-515.
42. Rafalowska J, Barcikowska M, Wen GY, Wisniewski HM. Laminar distribution of neuritic plaques in normal aging, Alzheimer's disease and Downs syndrome. Acta Neuropathol 1988;77:21-25.
43. Satou T, Cummings BJ, Head E, Nielson KA, Hahn F F, Milgram NW, Velaquez P, Cribbs DH, Tenner AJ, Cotman CW. The progression of beta-amyloid deposition in the frontal cortex of the aged canine. Brain Res 1997;774:35-43.
44. Saunders A, Strittmatter W, Schmechel D, St. George-Hyslop P, Pericak-Vance M, Joo S, Rose B, Gasella J, Crapper-MacLachan D, Albersts M, Hulette C, Crain B, Goldgaber D, Roses A. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
45. Serrano-Pozo A, Mielke ML, Muzitansky A, Gomez-Isla T, Growdon JH, Bacskai BJ, Betensky RA, Frosch M P, Hyman BT. Stable size distribution of amyloid plaques over the course of Alzheimer's disease. J Neuropath Exp Neurol 2012;71:694-701.
46. Sheng JG, Griffin V S T, Roystan MC, Mrak RE. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropath Appl Neurobiol 1998;24:278-283.
47. Sherrington R, Rogaev E, Liang Y, Rogaeva E, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar. L, Foncin J, Bruni A, Moulese M, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sauseau P, Polinski R, Wasco, R, Dasilva H, Haines J, Pericak-Vance M, Tanzi R, Roses A, Fraser P, Rommens J, St George-Hyslop P. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1993;375:754-760.
48. Sillén A, Forsell C, Lilius L, Axwlman K, Björk B, Onkamo P, Kere J, Winblad B, Graff C. Genome scan on Swedish Alzheimer disease families. Mol Psychiatry 2006;11:182-186.
49. Snedecor GW, Cochran WG. Statistical Methods. Iowa State University Press, Ames 1980.
50. Spargo E, Luthert PJ, Anderton BH, Bruce M, Smith D, Lantos PL. Antibodies raised against different proteins of A4 protein identify a subset of plaques in Down's syndrome. Neurosci Lett 1990;115:345-350.
51. Su Y, Ni BH. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. J Neurosci Res 1998;53:177-186.
52. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 1988;38:359-364.
53. Uchihara T, Duyckaerts C, Lazarini F, Mokhtari K, Seilhean D, Amouyel P, Hauw JJ. Inconsistent apolipoprotein (Apo E)-like immunoreactivity in amyloid beta protein deposits: relationship with Apo E genotype in aging brain and Alzheimer's disease. Acta Neuropathol 1996;92:180-185.
54. Van Hoesen GW, Parvizi J, Chu CC. Orbitofrontal cortex/pathology in Alzheimer's disease. Cerebral Cortex 2000;10:243-251.
55. Wallon D, Rovelet-Lecrux A, Deramecourt V, Pariente J, Auriacombe S, Le Ber I, Schraen S, Pasquier F, Campion D, Hannequin D. Definite behavioural variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. J Alz Dis 2012;32:19-22.